|
Aug 14
|
Cassava Reports Q2 2025 Financials Results and Provides Business Update
|
|
Aug 4
|
Cassava Sciences Reports Positive Preclinical Study Evaluating Simufilam for TSC-Related Epilepsy
|
|
Jun 30
|
Cassava Presents Promising Preclinical Simufilam Data at TSC Alliance Meeting
|
|
Feb 21
|
Cassava Gears Up to Report Q4 Earnings: What's in the Cards?
|